Goal 2: Reduce Human Disease

Drug Desensitization Protocols

As the current chair of the Research and Training Division, I would like to convey that the AAAAI membership would like the NHLBI to consider the following in the development of its strategic plan:


Given that increasing number of patients allergic to their best medications are treated with desensitization, which allows improved quality of life and prolongs their lives,  what  personalized, effective and safe protocols will be available to provide first line therapies to these patients?  

Tags (Keywords associated with the idea)

Is this idea a Compelling Question (CQ) or Critical Challenge (CC)? : Compelling Question (CQ)

Name of idea submitter and other team members who worked on this idea : Mitchell Grayson on behalf of the American Academy of Allergy, Asthma, and Immunology


-9 net votes
4 up votes
13 down votes
Idea No. 467